We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · October 04, 2018

Exenatide Corrects Postprandial Hyperglycemia in Youth With Cystic Fibrosis and Impaired Glucose Tolerance

Diabetes, Obesity & Metabolism


Additional Info

Diabetes, Obesity & Metabolism
Exenatide Corrects Postprandial Hyperglycaemia in Youth With Cystic Fibrosis and Impaired Glucose Tolerance: A Crossover Randomised Trial
Diabetes Obes Metab 2018 Sep 26;[EPub Ahead of Print], MC Geyer, T Sullivan, A Tai, J Morton, S Edwards, AJ Martin, SJ Perano, L Gagliardi, CK Rayner, M Horowitz, JJ Couper

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading